Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Liabilities from Discontinued Operations (2016)

Neuroone Medical Technologies' Liabilities from Discontinued Operations history spans 2 years, with the latest figure at 21807.0 for Q4 2016.

  • For Q4 2016, Liabilities from Discontinued Operations rose 10.02% year-over-year to 21807.0; the TTM value through Dec 2016 reached 21807.0, up 10.02%, while the annual FY2016 figure was 21807.0, 10.02% up from the prior year.
  • Liabilities from Discontinued Operations reached 21807.0 in Q4 2016 per NMTC's latest filing, roughly flat from 21807.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 21807.0 in Q2 2016 to a low of 19821.0 in Q4 2015.